Jornal de Hematologia e Doenças Tromboembólicas
Acesso livre

Abstrato

Editorial Note on Cancer

Lovely Gautam

Bone marrow or fringe blood undeveloped cell transplantation is utilized in the therapy of malignancy for two reasons. In the first place, transplantation licenses abuse of the lofty dose‐response relationship found in certain tumors by permitting organization of dosages of foundational chemotherapy and radiotherapy that without transplantation would cause unsatisfactorily extreme or deadly myelosuppression. Second, transplantation of allogeneic marrow presents an antitumor impact, separate from the impacts of chemoradiotherapy. The first fruitful bone marrow transfers in quite a while were acted in the last part of the 1960s.